Plano's Reata Pharmaceuticals strikes a $7.3 billion deal with biotech giant Biogen - The Dallas Morning News
dallasnews.comSubmitted by thedallasmorningnews8366 in business
Plano biotech firm Reata Pharmaceuticals, which only recently earned regulatory approval to begin selling a drug aimed at people with a rare neurological...